STADA ARZNEIMITTEL |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-1.95% | -8.87% |
| 2023 | Alvotech, Stada Get EU Panel Backing for Stelara Biosimilar | MT |
| 2021 | Sanofi Divests 16 Brands From European Consumer Healthcare Portfolio | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| STADA ARZNEIMITTEL | Generic Pharmaceuticals | -.--% | -1.95% | - | - | - | 5.73B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- SAZ Stock
- Charts STADA Arzneimittel
- Comparison Chart
